COMBOGESIC IV

Drug Hikma Pharmaceuticals USA
Total Payments
$22,142
Transactions
62
Doctors
61
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $22,142 62 61

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $21,964 60 99.2%
Food and Beverage $178.13 2 0.8%

Top Doctors Receiving Payments for COMBOGESIC IV — Page 3

Doctor Specialty Location Total Records
, M.D Sports Medicine Chevy Chase, MD $305.33 1
, M.D Specialist Goodlettsville, TN $305.33 1
, M.D Adult Reconstructive Orthopaedic Surgery Walnut Creek, CA $305.33 1
, MD Adult Reconstructive Orthopaedic Surgery Rancho Mirage, CA $305.33 1
, M.D., D.V.M Orthopaedic Surgery Lafayette, LA $305.33 1
, M.D Orthopaedic Surgery Providence, RI $305.33 1
, MD Orthopaedic Surgery Bristol, VA $305.33 1
, M.D Orthopaedic Surgery Catonsville, MD $305.33 1
, M.D Orthopaedic Surgery Beaufort, SC $305.33 1
, M.D Adult Reconstructive Orthopaedic Surgery Troy, MI $305.33 1
, D.P.M Podiatrist Pasadena, MD $178.13 2

About COMBOGESIC IV

COMBOGESIC IV is a drug associated with $22,142 in payments to 61 healthcare providers, recorded across 62 transactions in the CMS Open Payments database. The primary manufacturer is Hikma Pharmaceuticals USA.

Payment data is available from 2024 to 2024. In 2024, $22,142 was paid across 62 transactions to 61 doctors.

The most common payment nature for COMBOGESIC IV is "Consulting Fee" ($21,964, 99.2% of total).